Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Teva pharmaceutical industries ltd crawled time : 14:00 save search
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: -1.24%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 1.65%
H: 2.43%
C: 0.87%
reach treatment research market
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 2.54%
H: 3.23%
C: -1.29%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
revenue teva financial results
Nootropic Supplement Market to Register US$ 4,180 Million by 2033 Amid Rising Consumer Demand for Organic Health Boosters | Future Market Insights, Inc.
Published: 2023-10-18 (Crawled : 14:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
organic health market
Myasthenia Gravis Treatment Market to Grow Exponentially by 2029 | Brandessence Market Research
Published: 2023-09-18 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.7%
H: 0.0%
C: -5.11%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.72%
H: 0.13%
C: -0.93%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.02%
H: 0.18%
C: -0.78%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.06%
H: 0.44%
C: -0.64%
treatment research market
Teva to Present Data for AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, AUSTEDO® (deutetrabenazine) Tablets and UZEDY™ (risperidone) Extended-Release Injectable Suspension at Psych Congress 2023
Published: 2023-09-06 (Crawled : 14:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -0.31%
H: 0.1%
C: -0.52%
austedo congress teva
Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development
Published: 2023-07-27 (Crawled : 14:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -0.23%
H: 1.18%
C: -0.94%
business grant teva
Global Remifentanil Hydrochloride Market to Surpass USD 346.7 Mn By 2031| Growth Market Reports
Published: 2023-06-23 (Crawled : 14:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 0.64%
C: -0.02%
global growth market
Fibromyalgia Treatment Market to Reach $4.6 Billion, Globally, by 2032 at 4.0% CAGR: Allied Market Research
Published: 2023-06-16 (Crawled : 14:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.75%
H: 0.14%
C: 0.14%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.6%
H: 3.2%
C: 2.9%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.03%
H: 0.29%
C: -0.59%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.41%
H: 0.26%
C: -1.77%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.6%
H: 1.62%
C: 1.42%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.4%
H: 1.07%
C: 0.72%
fibromyalgia reach treatment research market
Teva to Present New Data on Once-Daily AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets at the 2023 American Academy of Neurology Annual Meeting
Published: 2023-04-11 (Crawled : 14:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 1.28%
H: 0.58%
C: -0.63%
austedo meeting teva
Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
Published: 2023-03-09 (Crawled : 14:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -0.1%
H: 0.31%
C: -3.32%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.46%
H: 0.18%
C: -1.61%
revlimid teva
Teva Announces Publication of New Clinician Scale in Journal of Clinical Psychiatry to Assess the Impact of Tardive Dyskinesia on Patients’ Lives
Published: 2023-02-23 (Crawled : 14:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: 0.8%
H: 0.3%
C: -0.3%
impact teva publication
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
Published: 2022-11-14 (Crawled : 14:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -2.74%
H: 4.56%
C: 1.3%
collaboration health teva unique respiratory platform
CONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder and Digihaler System to Help Improve Asthma Management
Published: 2022-09-07 (Crawled : 14:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -0.11%
H: 2.06%
C: 1.26%
proair management system potential study
Depression Drugs Market to Surpass US$ 20 Billion by 2031 as Demand for Serotonin-norepinephrine Reuptake Inhibitors Surges
Published: 2022-08-11 (Crawled : 14:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.83%
H: 0.79%
C: -0.29%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.18%
H: 1.46%
C: 0.05%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: -0.08%
H: 0.51%
C: -0.62%
depression market
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is Predicted to Expand at a CAGR of 4.4% during the Forecast Period, notes TMR Study
Published: 2022-07-07 (Crawled : 14:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
treatment disease study market
Global Genitourinary Drugs Market Research Report to 2027 - Increasing Prevalence of Genitourinary Disorders is Driving Growth
Published: 2022-04-26 (Crawled : 14:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: 2.56%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.13%
H: 0.06%
C: -0.69%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 3.08%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.47%
H: 0.83%
C: -1.44%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 2.0%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.34%
H: 1.41%
C: -1.17%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: -0.12%
H: 0.07%
C: -5.13%
research report growth market drug
Global CNS Therapeutics Market Report 2022 - CNS Therapeutics Exhibit Robust Opportunities amidst Rising Incidence of CNS Disorders
Published: 2022-03-22 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.9%
H: 0.0%
C: -8.17%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.88%
H: 2.09%
C: 2.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -0.02%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
NBIX M | $132.03 -0.39% -0.39% 560K
|
Health Technology
|
| O: 0.04%
H: 1.77%
C: 0.65%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: -0.19%
H: 2.09%
C: 1.01%
therapeutics report
Melamine Market to Reach $2.5 Bn, Globally, by 2030 at 4.3% CAGR: Allied Market Research
Published: 2022-01-31 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
research market
Teva Announces Launch of an Authorized Generic of Epiduo® Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the U.S.
Published: 2021-12-01 (Crawled : 14:00) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -1.64%
H: 1.25%
C: -2.73%
authorized
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.